Madrigal Pharmaceuticals (MDGL) Peer Comparison

$427.39

up-down-arrow $2.18 (0.51%)

As on 13-Nov-2026 16:01EST

Market cap

info icon

$9,928 Mln

Revenue (TTM)

info icon

$1,428 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

15.8

Div. Yield

info icon

0 %

Edit peer-selector-edit
Madrigal Pharmaceuticals (MDGL) Exelixis (EXEL) Ascendis Pharma A/S - ADR Halozyme Therapeutics (HALO) Kymera Therapeutics (KYMR)
Market cap ($ Mln)
9,928 16,837 18,064 11,432 10,891
Revenue ($ Mln)
1,428 2,497 1,208 1,802 102
Net Profit ($ Mln)
-155.46 885.14 890.37 485.42 -349.47
Net Margin (%)
-10.89 35.45 73.69 26.93 -341.87
RoE (%)
-26.57 46.96 88.40 -- -22.16
Price to Earnings
-- 20.66 18.11 25.19 --
Price-To-Book
15.76 9.18 10.44 97.15 6.72

Income Statement ($ Mln)

Liabilities ($ Mln)

Assets ($ Mln)

Cashflow ($ Mln)

Ratios

Profitability Ratios

Growth Ratios

Valuation Ratios

Solvency Ratios

Operating Efficiency Ratios

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...

Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.

Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month